KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation

AMS:PHIA • NL0000009538

24.41 EUR
-0.21 (-0.85%)
Last: Mar 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. PHIA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year PHIA was profitable.
  • In the past year PHIA had a positive cash flow from operations.
  • In multiple years PHIA reported negative net income over the last 5 years.
  • PHIA had a positive operating cash flow in 4 of the past 5 years.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.32%, PHIA is in line with its industry, outperforming 49.23% of the companies in the same industry.
  • PHIA has a Return On Equity of 8.17%. This is comparable to the rest of the industry: PHIA outperforms 58.46% of its industry peers.
  • The Return On Invested Capital of PHIA (5.50%) is comparable to the rest of the industry.
  • PHIA had an Average Return On Invested Capital over the past 3 years of 3.48%. This is significantly below the industry average of 10.72%.
  • The last Return On Invested Capital (5.50%) for PHIA is above the 3 year average (3.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHIA has a Profit Margin (5.02%) which is comparable to the rest of the industry.
  • PHIA's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 7.98%, PHIA perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PHIA has declined.
  • PHIA has a Gross Margin of 45.18%. This is in the lower half of the industry: PHIA underperforms 75.38% of its industry peers.
  • PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. PHIA.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHIA is destroying value.
  • PHIA has more shares outstanding than it did 1 year ago.
  • PHIA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for PHIA is higher compared to a year ago.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.02 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.02, PHIA is doing worse than 60.00% of the companies in the same industry.
  • PHIA has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHIA would need 16.37 years to pay back of all of its debts.
  • PHIA has a Debt to FCF ratio of 16.37. This is in the lower half of the industry: PHIA underperforms 60.00% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that PHIA is somewhat dependend on debt financing.
  • PHIA's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. PHIA is outperformed by 64.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.02
ROIC/WACC0.84
WACC6.55%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, PHIA is in line with its industry, outperforming 41.54% of the companies in the same industry.
  • A Quick Ratio of 0.94 indicates that PHIA may have some problems paying its short term obligations.
  • PHIA has a Quick ratio of 0.94. This is in the lower half of the industry: PHIA underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHIA.AS Growth Analysis

3.1 Past

  • PHIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.11%.
  • Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
  • Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -1.03% in the last year.
  • Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.24% on average over the next years. This is quite good.
  • PHIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.78% yearly.
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHIA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.61 indicates a correct valuation of PHIA.
  • Based on the Price/Earnings ratio, PHIA is valued cheaper than 87.69% of the companies in the same industry.
  • PHIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.70.
  • Based on the Price/Forward Earnings ratio of 15.96, the valuation of PHIA can be described as correct.
  • Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. PHIA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.61
Fwd PE 15.96
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 73.85% of the companies in the same industry are more expensive than PHIA, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 47.58
EV/EBITDA 11.38
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHIA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.11
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHIA.AS Dividend Analysis

5.1 Amount

  • No dividends for PHIA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHIA.AS Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NV

AMS:PHIA (3/13/2026, 7:00:00 PM)

24.41

-0.21 (-0.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners47.46%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.51B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts75.33
Price Target29.32 (20.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)7.51%
PT rev (3m)6.07%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE 16.61
Fwd PE 15.96
P/S 1.32
P/FCF 47.58
P/OCF 20.23
P/B 2.15
P/tB N/A
EV/EBITDA 11.38
EPS(TTM)1.47
EY6.02%
EPS(NY)1.53
Fwd EY6.27%
FCF(TTM)0.51
FCFY2.1%
OCF(TTM)1.21
OCFY4.94%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)4.11
PEG (5Y)N/A
Graham Number19.4
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.02
F-Score7
WACC6.55%
ROIC/WACC0.84
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.67%
EBIT Next 3Y26.47%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 3 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 1 / 10.


Can you provide the dividend sustainability for PHIA stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 36.65%.